Roshal Health Announces $10 Million in Structured Equity Financing Led by Catalio Capital Management

HOUSTON–(BUSINESS WIRE)–Roshal Health, a new leader providing hospital grade, on-site, and on-demand ultrasound and echocardiogram services to ERs, micro-hospitals, rural hospitals, and hospital offsite facilities, today announced that it secured $10 million in financing.


The structured equity financing was led by Catalio Capital Management, a leading multi-strategy healthcare and life science investment firm, with participation from Green Street Impact Partners.

Employing more than 300 people, Roshal offers services to hospital systems, standalone emergency rooms, micro-hospitals, rural hospitals, and offsite facilities nationwide. The funds will be used to advance Roshal’s tech-enabled platform to address imaging technician staffing shortages at healthcare service providers, eliminating costly gaps in care delivery through a highly scalable model.

“Catalio is thrilled to work alongside the Roshal team to solve a critical healthcare staffing shortage for imaging technicians,” said John Henry Iucker, CFA, General Partner and Head of Credit at Catalio Capital Management. “This collaboration demonstrates alternative financing models as an attractive solution for dynamic and fast-growing companies in a challenging fundraising environment.”

“We are grateful to be working with Catalio Capital Management and Green Street Impact Partners, whose extensive expertise in the healthcare sector will contribute to unlocking Roshal’s full potential,” said Michael Hall, CEO of Roshal Health. “This is an important next step in our journey and will further bolster our ability to meet customer care delivery targets with cost-efficient and high-quality diagnostic services.”

Catalio Capital Management was advised by legal counsel Covington and Burling LLP, Locke Lord LLP served as legal counsel to Green Street Impact Partners. Uplift Partners served as the exclusive financial advisor to Roshal Health, and DLA Piper served as legal counsel to the company.

About Catalio Capital Management

Catalio Capital Management, LP, is a multi-strategy healthcare and life sciences investment firm focusing on breakthrough companies developing the next generation of drugs, devices, diagnostics, and data-driven insights. Catalio’s Partnership includes over 44 world-renowned scientists with extensive academic and scientific achievements who have each started well-established companies based on their research. Catalio has offices in New York and London. Learn more about Catalio Capital Management by visiting www.cataliocapital.com.

About Green Street Impact Partners

Green Street Impact Partners is a sector-specific private equity fund that invests growth capital in companies leveraging technologies to catalyze innovation across the education lifecycle, from K-12, to higher education, to workforce learning. As experienced investors and operators–including former policymakers, educators, and college leaders–our focus is the intersection of learning and economic mobility. For more information, visit https://gsimpactpartners.com/.

About Roshal Health Services

Based in Greater Houston, TX, Roshal Health Services is a new leader providing hospital grade, on-site, and on-demand ultrasound and echocardiogram services to ERs, micro-hospitals, rural hospitals, and hospital offsite facilities. Roshal’s services enable providers to employ diagnostic tools early to detect and prevent disease onset. To learn more, please visit www.roshalimaging.com.

Contacts

Charles V. Zehren

212-843-8590

[email protected]

Subscribe on LinkedIn

Get the free newsletter

Subscribe to MedicaEx for top news, trends & analysis

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Businesswire is solely responsible for the content of the above news submissions. If there are any violations of laws, violations of the membership terms of this website, or the risk of infringing on the rights of third parties, businesswire will be solely responsible for legal and damage compensation. Responsibility has nothing to do with MedicaEx.

Are you in?

Subscribe to receive exclusive content and notifications to your inbox

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.